A9 Tck as Therapeutic Targets

Date:
1999-2007
Reference:
SA/KET/A/4/1/9
Part of:
The Kennedy Trust for Rheumatology Research
  • Archives and manuscripts

About this work

Description

Item relates to patent A9 "Tck as Therapeutic Targets," invented by Marc Feldmann, Brian Foxwell and Fionula Brennan under applicant Synovis Ltd and The Kennedy Institute of Rheumatology. The patent is also referred to as "Therapeutic Methods and Compounds", "Tck Cells" and "Tck Inhibitors".

The item contains papers relating to the filing and prosecution progress for UK, International PCT, European, Canadian, US, Australian, Hong Kong and Japanese applications.

See related material for A9 Espacenet listing (includes patent abstract and digital copies of application).

Publication/Creation

1999-2007

Physical description

1 file (in 3 parts)

Related material

Terms of use

This item is held in offsite storage and requires a longer time for delivery.

Where to find it

  • LocationStatusAccess
    Closed stores

Permanent link